Neuropace shares owned by UBS Group
Historical chart of UBS Group investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $673k | 65k | 10.31 |
| 2025-06-30 | $301k | 27k | 11.14 |
| 2025-03-31 | $320k | 26k | 12.29 |
| 2024-12-31 | $77k | 6.9k | 11.19 |
| 2024-09-30 | $29k | 4.1k | 6.97 |
| 2024-06-30 | $31k | 4.1k | 7.56 |
| 2024-03-31 | $22k | 1.7k | 13.20 |
| 2023-09-30 | $535 | 55 | 9.73 |
| 2023-03-31 | $12k | 2.6k | 4.64 |
| 2022-12-31 | $2.3k | 1.6k | 1.49 |
| 2022-09-30 | $8.0k | 2.2k | 3.68 |
| 2022-03-31 | $1.0k | 101 | 9.90 |
| 2021-12-31 | $38k | 3.7k | 10.29 |
| 2021-06-30 | $61k | 2.6k | 23.80 |